Phase I Study of Pazopanib and Ixabepilone in Patients With Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 29 Jun 2017
At a glance
- Drugs Ixabepilone (Primary) ; Pazopanib (Primary)
- Indications Breast cancer; Colon cancer; Head and neck cancer; Liver cancer; Lung cancer; Pancreatic cancer; Renal cancer; Sarcoma; Solid tumours
- Focus Adverse reactions
- 22 Jan 2016 Status changed from completed to discontinued as reported by ClinicalTrials.gov record.
- 09 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 29 May 2012 Status changed from suspended to recruiting as reported by ClinicalTrials.gov.